Discovery of potent triterpenoid and limonoid compounds targeting Mycobacterium tuberculosis enoyl acyl carrier protein reductase (InhA): An in silico investigation

Drug resistance remains one of the primary concerns in treating tuberculosis (TB), making it imperative to find new and effective drug candidates for improved TB treatment. Enoyl acyl carrier protein reductase (InhA), an enzyme involved in mycolic acid biosynthesis, is crucial for anti-TB drug activ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Informatics in medicine unlocked Jg. 40; S. 101299
Hauptverfasser: Pitaloka, Dian Ayu Eka, Arfan, Arfan, Alfarafisa, Nayla Majeda, Chaidir, Lidya, Supratman, Unang
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Elsevier Ltd 2023
Elsevier
Schlagworte:
Docking
Dynamics studies
Limonoid
Mycobacterium tuberculosis-Resistance
Triterpenoid
Docking
Dynamics studies
Limonoid
Triterpenoid
Mycobacterium tuberculosis-Resistance
ISSN:2352-9148, 2352-9148
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Drug resistance remains one of the primary concerns in treating tuberculosis (TB), making it imperative to find new and effective drug candidates for improved TB treatment. Enoyl acyl carrier protein reductase (InhA), an enzyme involved in mycolic acid biosynthesis, is crucial for anti-TB drug activity such as isoniazid (INH). Triterpenoids and limonoids are widespread in the plant kingdom and have gained much attention in their development as anti-TB agents. This study aims to examine the potential of triterpenoid and limonoid compounds as InhA inhibitors based on binding energy, interaction mode, and binding stability using docking and molecular dynamics (MD) investigation. Chisopatens A (−10.93 kcal/mol), 3-epi-cabraleahydroxy lactone (−9.85 kcal/mol), and 3-oxo-olean-11(12)en-28-oic acid (−9.73 kcal/mol), as well as 6α-(acetoxy)-14β,15β-epoxyazadirone (−9.77 kcal/mol), an azadirone-type limonoid derivative, have the best affinity for Leu63, Gly96, and Lys165 amino acid residues from InhA compared to native ligand (NAD) analyzed by docking studies. Chisopatens A, 3-epi-cabraleahydroxy lactone, and 3-oxo-olean-11(12)en-28-oic also had the best affinity for InhA based on MM-PBSA analysis, with values of −140.676 kJ/mol, −108.888 kJ/mol, and −162.605 kJ/mol, respectively. During dynamics studies, these compounds also showed good stability, protein compactness, and high-intensity interaction with InhA. These results strongly support future in-vitro studies to evaluate the efficacy of the hit compounds for treating INH-resistant MTB strains.
ISSN:2352-9148
2352-9148
DOI:10.1016/j.imu.2023.101299